A microfluidics-based platform for conducting blood tests with significantly reduced sample volume requirements. The technology integrates fluid handling, reagent storage, and analysis capabilities within a compact disposable cartridge format.
Manufactured by
CytoChip Inc.
United States
CitoCBC® is the world's first cartridge-based Complete Blood Count (CBC) test with FDA 510(k) clearance and CLIA Waiver, which enables lab-quality results at the point of care. CytoChip is launching this product in the U.S. with a national distributor and seeks distribution partners for global markets. This product uses fluorescent flow cytometry technology, which can also be used for automated Platelet Enriched Plasma (PRP) testing.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Micropoint Bioscience, Inc.
United States · 3 relevant products
Sciverse Solutions
India · 1 relevant product
ZIODIA Co., Ltd.
South Korea · 2 relevant products
22 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 36 closest product alternatives
Micropoint Bioscience, Inc. · United States
A microfluidic-based platform for lab-level accuracy point-of-care testing. The platform serves as the foundation for multiple specialized diagnostic solutions including cardiovascular, diabetes and kidney injury, inflammation, and fertility testing applications.
Sciverse Solutions · India
A portable molecular diagnostics system featuring a disposable microfluidic cartridge for closed-system nucleic acid testing with zero cross-contamination. The platform supports up to 32-plex multiplexing, delivers results in 45 minutes, and is available in handheld and benchtop configurations with customizable assays including a ready-to-deploy COVID-19 panel.
ZIODIA Co., Ltd. · South Korea
Compact platform for performing in vitro diagnostic testing utilizing advanced microfluidic technology. Delivers laboratory-quality results while reducing time to diagnosis and associated testing costs.
33 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products